Agereh Technologies Announces Revised Terms of Non-brokered Private Placement

Rhea-AI Summary

Agereh Technologies (OTCQB:CRBAF) revised terms for its previously announced non-brokered private placement on October 14, 2025. The Offering now consists of up to 10,000,000 Units at $0.05 per Unit for gross proceeds up to $500,000. Each Unit comprises one common share and one warrant exercisable at $0.10 for 24 months from issuance.

The Units are being offered under the listed issuer financing exemption (LIFE) in all Canadian provinces except Québec, and the Units and underlying securities will not be subject to Canadian resale restrictions. An offering document will be filed on Sedarplus and the company website. The Offering remains subject to customary conditions, including conditional TSXV approval.

Positive

• Gross proceeds up to $500,000
• Each Unit includes a 24-month warrant
• Offered under LIFE exemption (no resale restrictions)

Negative

• Issuance of up to 10,000,000 shares may dilute existing holders
• Warrant exercise at $0.10 could increase dilution if exercised
• Offering is subject to TSXV conditional approval

EDMONTON, AB / ACCESS Newswire / October 14, 2025 / Agereh Technologies Inc. ("Agereh" or the "Company") (TSXV:AUTO)(OTCQB:CRBAF) announces that further to its news releases dated August 27, 2025, the Company has revised the terms of its previously announced non-brokered private placement (the "Offering) of common shares. The Offering will now consist of up to 10,000,000 units of the Company ("Units") at a price of $0.05 per Unit, for aggregate gross proceeds of up to $500,000. Each Unit will consist of one common shares (each a "Unit Share") and one common share purchase warrant (a "Unit Warrant"), with each Unit Warrant being exercisable to purchase one additional Unit Share at a price of $0.10 for twenty-four (24) months from the date of issuance.

The Units to be issued under the Offering will be offered to purchasers pursuant to the listed issuer financing exemption (LIFE) under Part 5A of National Instrument 45-106 - Prospectus Exemptions ("NI 45-106"), in all the provinces of Canada, except Québec. The Units, including the Unit Shares and Unit Warrants underlying the Unit, will not be subject to resale restrictions pursuant to applicable Canadian securities laws.

An offering document relating to the Offering will be filed and accessible under the Company's profile at www.sedarplus.ca and on the Company's website at www.agereh.com. Prospective investors should read this offering document before making an investment decision.

The Offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the conditional approval of the TSX Venture Exchange (the "TSXV").

About Agereh Technologies Inc.

Agereh is a Canadian-based AI technology company whose platforms target advanced technology solutions for the transportation industry. The first application developed is harnessing the power of Artificial Intelligence to accurately predict the best financing scenario for consumers, all while keeping the consumer anonymous. Upcoming products will continue to deliver advanced technology solutions that address critical challenges in the transportation industry.

ON BEHALF OF THE BOARD OF DIRECTORS OF Agereh Technologies INC.

Ken Brizel, CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Ken Brizel
CEO
info@agereh.com
Website: www.agereh.com

Notice Regarding Forward-Looking Information:

This news release contains forward-looking statements including but not limited to statements regarding the Company's business, assets or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.

SOURCE: Agereh Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What are the terms of Agereh Technologies' revised private placement (CRBAF) on October 14, 2025?

Up to 10,000,000 Units at $0.05 per Unit for up to $500,000; each Unit includes one share and one warrant exercisable at $0.10 for 24 months.

How will the CRBAF offering be sold to investors and where is it available?

Units will be offered under the LIFE exemption across Canada except Québec; an offering document will be filed on Sedarplus and the company website.

Will Agereh (CRBAF) shares from the offering be subject to resale restrictions?

No; the Units and underlying shares and warrants will not be subject to resale restrictions under applicable Canadian securities laws.

What dilution risk does the Agereh (CRBAF) offering present to current shareholders?

The offering could issue up to 10,000,000 new shares plus warrants exercisable at $0.10, which may materially dilute existing holdings if fully issued and exercised.

Is the Agereh (CRBAF) offering finalized and when does it take effect?

The Offering is subject to certain conditions, including conditional approval from the TSXV, so it is not final until those approvals are received.